Hi, I am attaching some comments, observations and feedback to this white paper which if possible we would like to discuss and clarify during the call today. It is possible that we are mis-interpreting certain items and observations made within this white paper so clarifications by members of this group and authors of this white paper during the call today will allow us to resolve them.
I have attached a word document detailing the items. Thanks, sunny -----Original Message----- From: [EMAIL PROTECTED] [mailto:[EMAIL PROTECTED]] Sent: Monday, June 10, 2002 12:12 PM To: [EMAIL PROTECTED] Subject: SNIP Testing Minutes 6/6/02 Transaction Testing SWG Minutes from the Conference Call Meeting held Thursday, June 6, 2002 The purpose of this call was to review the version of the Certification and Compliance Testing White Paper currently being developed. John quickly re-explained the rationale behind issuing an updated version of Appendix A, without waiting for the rest of the completely revised paper. The group feels that Appendix A is so obsolete, and inaccurate that a more current copy needs to go to the website as soon as possible and not be held up by the extensive changes to the entire paper. John also looked for volunteers to take over "coordinatorship" / "ownership", the original writers focuses' have broadened out into many other areas. And again, there were no volunteers. John resigned to taking over the assignment himself. The tone of the document was the primary topic much of the call. - being sure to include a 'vendor neutral' statement in the paper to reiterate that we are not endorsing, sponsoring, or specifically singling out one vendor over another. We are all volunteers who are employed by organizations, some of these organizations are in a position, and are philanthropic enough to take advantage of the position, to lend their support in more ways than by offering volunteers. This additional support should not be seen as an endorsement by WEDI SNIP of that organization or its products. - being sure the tone of the new version is toward 'validation' downplaying 'certification' This discussion led to another discussion about the approach to testing and Type #7 - Should the approach involve just the Implementation Guides or the Partner compliance agreements (so-called Companion Guides) - Are Partner compliance agreements (so-called Companion Guides) appropriate to the Business-To-Business Testing paper, while this Compliance Testing paper should refer to the special payors/program testing specifically referred to in the Rule (Medicare, Medicaid, Indian Health.) - Examples were given to illustrate that validating companion testing and the Guides have many of the same aspects including standards validation. - Most on the call want the name/description for Type #7 changed - It seemed to be generally accepted that the compliance testing paper would refer the reader to the B-2-B paper and have a more thorough discussion in that paper. However, we are going to stay focused on completing and issuing the Compliance testing paper and not get sidetracked with beginning to develop a new version of the B-2-B right now. - Comments were also made regarding the misconception of Certification being mandated. Quoting from page 50342 of the TCS Final Rule: "Since the HIPAA provisions do not require the Secretary to certify compliance with HIPAA standards, the Secretary is not conducting certification reviews or recognizing private organizations that have decided to conduct such reviews. Therefore, any certification of commercial entities performing validation testing will remain in the private domain and be voluntary. While receivers of transactions are likely to test whether a vendor that claims to be HIPAA compliant is, in fact, producing compliant transactions, this is a matter of business practice, and such tests are not being mandated in this rule." John committed to issuing an updated document by the Monday before the next call ... so Monday June 17. The remainder of the time on the call was then turned over to Sanjeev Kulkarni for a review of his concerns regarding Test Files received and made available through SNIP. He talked about need to statements about the objective, purpose and description to accompany each file. The Submitter should also identify who validated the material in the file. This way entities who were interested in Home Infusion Therapy Tests would be able to pick these files and not "waste" test time by picking a test file with Ambulance Claims. Claredi has indicated that they have adequate storage available for the 'public' to submit their test files, and we won't have to link to multiple sites. Sanjeev will write and distribute his suggestions for us to review before the next call. The tentative agenda for the next call ... Thursday June 20th ... 8 AM Pacific ... 11 AM Eastern at 703.736.7290 pass code 1315339 Review Compliance Testing White Paper - John's updates as well as - Sanjeev's review Review of Sanjeev's Test File recommendations If you have any questions, or your notes don't agree with mine, please let me know. Marsha Verizon Information Technologies Inc. Managed Care Division Phoenix, AZ HOME OF THE WORLD CHAMPION ARIZONA DIAMONDBACKS Phone - 602.678.6042 Fax - 602.678.6331 E-mail - [EMAIL PROTECTED] Confidentiality Notice: This e-mail message, including any attachments, is for the sole use of the intended recipient(s) and may contain confidential and privileged information. Any unauthorized review, use, disclosure or distribution is prohibited. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies of the original message. ********************************************************************** To be removed from this list, send a message to: [EMAIL PROTECTED] Please note that it may take up to 72 hours to process your request. Please note that it may take up to 72 hours to process your request. <P>The WEDI SNIP listserv to which you are subscribed is not moderated. The discussions on this listserv therefore represent the views of the individual participants, and do not necessarily represent the views of the WEDI Board of Directors nor WEDI SNIP. If you wish to receive an official opinion, post your question to the WEDI SNIP Issues Database at http://snip.wedi.org/tracking/. Posting of advertisements or other commercial use of this listserv is specifically prohibited.
Comments on Transaction Compliance & Certification White Paper - Edifecs.doc
Description: MS-Word document
